Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Ascelia Pharma - Filing #701899

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
129 523 SEK
99 747 SEK
Revenue
- SEK
- SEK
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
116 559 SEK
85 527 SEK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
38,000 SEK
75 991 SEK
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
184 871 SEK
92 725 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.